ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0144

More Than a Monolith: Disaggregating Rheumatoid Arthritis Prevalence Among Asian American Subgroups

John Chen1, Tanya Selvam1, Jeanne Darbinian2, Christopher Macko1, Nirmala Ramalingam2, Joan Lo2 and Lucy Liu2, 1Kaiser Permanente Oakland Medical Center, Oakland, CA, 2Kaiser Permanente, Oakland, CA

Meeting: ACR Convergence 2024

Keywords: Demographics, population studies, race/ethnicity, rheumatoid arthritis, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a disabling, autoimmune condition affecting up to as many as 17.6 million individuals worldwide. Epidemiologic evidence in the United States thus far suggests RA may be less prevalent among those of Asian and Pacific Islander (Asian/PI) descent compared to those of African or European descent. However, there are many many racial and ethnic subgroups that comprise the Asian/PI label, and aggregating these subgroups has been shown to miss inter-group differences in prevalence of many diseases. In the RA literature, this study is the first to analyze RA prevalence in the United States among disaggregated Asian/PI subgroups. Understanding the demographics of RA on this level is important in further elucidating disparities in RA diagnosis, treatment, and prognosis.

Methods: Data from population of women aged 65-85 years in Kaiser Permanente Northern California (KPNC) during 2017-2019 were examined to determine the prevalence of rheumatoid arthritis by race and ethnicity and by Asian/PI subgroups. Race and ethnicity were ascertained from self-reported data in electronic health record and administrative databases. Identification of RA was based on ICD-9/10-coded clinical diagnosis at KPNC rheumatology clinic encounters between 2017-2019. Log-binomial regression was used to estimate prevalence ratios (PR) by race and ethnicity with 95% confidence intervals (CI), adjusted for age.

Results: Among 303,340 women, 60.1% were non-Hispanic White (NHW), 6.7% Black, 8.8% Hispanic, 16.0% Asian/PI, and 8.5% Other. There were 4161 women with RA, with an overall RA prevalence of 1.4%. By race and ethnicity, the prevalence ranged from 1.1% NHW, 1.2% Asian/PI, 2.2% Black, and 2.2% Hispanic, but among Asian/PI subgroups, the prevalence ranged from 1.0% Filipina, 1.1% Chinese, 1.1% Vietnamese or other Southeast Asian, 1.8% Korean, 1.9% Japanese, 2.5% Native Hawaiian/PI, NHPI, and 2.8% South Asian (Figure 1). The corresponding PRs with NHW as reference (Figure 2), were Black 1.9, Hispanic 1.9, Filipina 0.9, Chinese 1.0, Southeast Asian 1.0, Japanese 1.6, Korean 1.6, NHPI 2.2 and South Asian 2.5.

Conclusion: Compared to NHW women, this study demonstrated RA prevalence was 1.9-fold higher for Black and Hispanic women but similar for aggregated Asian/PI women. However, disaggregated findings in our study among Asian/PI subgroups showed 1.6-fold higher prevalence among Japanese and Korean women and >2-fold higher prevalence among South Asian and NHPI women compared to NHW women. This study elucidates how aggregating racial categories obscures heterogeneity amongst the subgroups. Prior studies have found meaningful clinical differences by racial categories in more than just RA prevalence. For example, minority groups were found to have higher RA disease activity scores and lower rates of remission. This knowledge gap in the epidemiology of RA hinders our comprehension of the clinical impact of RA and the existence of health disparities among Asian/PI RA patients. Future studies should examine whether characteristics of RA such as initial clinical presentation, disease activity, disability, extraarticular complications, and mortality, differ among these Asian/PI ethnic groups.

Supporting image 1

Figure 1: Prevalence of RA by Race/Asian Ethnicity

Supporting image 2

Figure 2: Prevalence ratios by race/ethnicity.


Disclosures: J. Chen: None; T. Selvam: None; J. Darbinian: None; C. Macko: None; N. Ramalingam: None; J. Lo: None; L. Liu: None.

To cite this abstract in AMA style:

Chen J, Selvam T, Darbinian J, Macko C, Ramalingam N, Lo J, Liu L. More Than a Monolith: Disaggregating Rheumatoid Arthritis Prevalence Among Asian American Subgroups [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/more-than-a-monolith-disaggregating-rheumatoid-arthritis-prevalence-among-asian-american-subgroups/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/more-than-a-monolith-disaggregating-rheumatoid-arthritis-prevalence-among-asian-american-subgroups/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology